ICarbonX

Shenzhen, China Founded: 2015 • Age: 11 yrs Unicorn
Bioinformatics platforms are provided for health management and drug development.

About ICarbonX

ICarbonX is a Healthcare company based in Shenzhen (China) founded in 2015 by Yingrui Li, Chun Wu, Hao Li, and Jun Wang. Bioinformatics platforms are provided for health management and drug development. It operates in the Healthcare and Technology sectors. ICarbonX has raised $365.68 million across 5 funding rounds from investors including Tencent, Vcanbio Cell & Gene Engineering Corporation and Beijing Rongzhilian Technology. The company has 64 employees. ICarbonX has completed 1 acquisition, including Imagu. ICarbonX was last valued at $1 billion in January 2018. Its chief executive, as recorded, is Jun Wang. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Drug Informatics.

Company details

iCarbonX was founded in 2015 in Shenzhen, China, focusing on bioinformatics for health management and drug development. Big data and artificial intelligence are utilized to analyze omic data alongside phenotypic, social, and environmental information. This analysis supports individual health management and pharmaceutical drug development. Key solutions include the Hey me platform for genetic testing, sports tracking, and personalized plans; the Healthtell immune response chip; and DigitalMe for chronic disease monitoring.

  • Headquarters Shenzhen, China
  • Employees 64
  • Founders Yingrui Li, Chun Wu, Hao Li, Jun Wang
  • Stage Unicorn
  • Sectors
    Healthcare
    Technology
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website icarbonx.com
  • Social LinkedIn X
Key Metrics
  • Total Equity Funding
    $365.68M (USD)

    in 5 rounds

  • Latest Funding Round
    $151M (USD), Series D

    Apr 2021

  • Investors
    Tencent

    & 10 more

  • Employee Count
    64
  • Investments & Acquisitions

Funding Insights of ICarbonX

ICarbonX has successfully raised a total of $365.68M across 5 strategic funding rounds. The most recent funding activity was a Series D round of $151 million completed in April 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $365.68M
  • Total Rounds 5
  • Last Round Series D β€” $151M
  • First Round $15M

    (Jan 2016)

  • Investors Count 11

All 5 funding rounds of ICarbonX with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Apr 2021$151MSeries D–China Money Network, China Investment Corporation
–
Jun 2018Series A–Wealthking Investments
–
Jul 2016$45MSeries A–China Bridge Capital
–
Apr 2016$154.68MSeries A$1BTencent
Jan 2016$15MSeries A–Vcanbio Cell & Gene Engineering Corporation
–
Valuation history
DateValuationStage
Apr 2016$1Bβ€’β€’β€’β€’β€’β€’β€’β€’

Last known valuation $1B (Jan 2018). 11 investors in total: 11 institutional.

Investors in ICarbonX

ICarbonX has secured backing from 11 investors, including institutional and venture fund investors. Prominent investors backing the company include Tencent, Vcanbio Cell & Gene Engineering Corporation and Beijing Rongzhilian Technology.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
A venture capital firm based in Shenzhen, China, is operated.
sharecapital.cnShenzhen, China
Early-stage centric sector-agnostic venture capital firm funding companies in the US
threeleafventures.comDenver, United States
Corporate-backed venture capital is focused on fintech and multiple sectors.
thirdpointventures.comMenlo Park, United States
Investments are directed toward early and growth stage companies.
quancapital.comPudong, China
Investment data and intelligence on Chinese markets are provided.
2011chinamoneynetwork.com
Serves as China's sovereign wealth fund, managing strategic investments globally.
2007china-inv.cnBeijing, China
wealthking.com.hk
chinabridgecapital.com
Bioreagents for genomic research and cell culture are supplied.
2009vcanbio.comTianjin, China
Value-added internet, mobile, and telecom services are provided in China.
1998tencent.comShenzhen, China
Premium access

Investor details for ICarbonX

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of ICarbonX

7 people are tracked at ICarbonX (6 in leadership, 1 in team); the tracked headcount is 64.

NameRoleGroup
Yingrui Li
Co-Founder & Chief ScientistLeadership
Chun Wu
Co-Founder & COOLeadership
Hao Li
Co-Founder & CIOLeadership
Jun Wang
Co-Founder & CEOLeadership
Leon Yao
Senior IT DirectorLeadership
Cynthia Jin 金雯飞
VP of Marketing & OperationLeadership
Xiaoxi Feng
Product Manager(work with Israel AI team)Team
Premium access

Complete people profiles for ICarbonX

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Investments & Acquisitions by ICarbonX

ICarbonX has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Imagu.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Object recognition software is developed for multiple industries.
imagutech.comTel Aviv, Israel2005Sep 2016β€’β€’β€’β€’
Premium access

Complete acquisition details for ICarbonX

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of ICarbonX

5 dated milestones of ICarbonX across 6 years, from founding to its latest funding, stage changes and deals.

  1. Founded ICarbonX is founded.
  2. Funding First funding round of $15.0M.
  3. Milestone Reaches Unicorn status.
  4. Acquisition Acquires Imagu.
  5. Funding Latest funding round, Series D, of $151.0M.
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Icarbonx

Premium access

Complete news archive for ICarbonX

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about ICarbonX

ICarbonX was founded in 2015 and raised its 1st funding round 1 year after it was founded.

ICarbonX is headquartered in Shenzhen, China. It is registered at Shenzhen, Guangdong, China.

Jun Wang is the CEO of ICarbonX, as recorded in our data. They have also founded this company.

ICarbonX is a funded company, having raised a total of $365.68M across 5 funding rounds to date. The company's 1st funding round was a Series A of $15M, raised on Jan 2016.

ICarbonX has 64 employees.

iCarbonX was founded in 2015 in Shenzhen, China, focusing on bioinformatics for health management and drug development. Big data and artificial intelligence are utilized to analyze omic data alongside phenotypic, social, and environmental information. This analysis supports individual health management and pharmaceutical drug development. Key solutions include the Hey me platform for genetic testing, sports tracking, and personalized plans; the Healthtell immune response chip; and DigitalMe for chronic disease monitoring.

ICarbonX has made 1 acquisition, including Imagu.

The valuation of ICarbonX is $1B as of Jan 2018.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available